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BIATRIAL COX MAZE IV: WE
ARE GOING IN THE RIGHT
DIRECTION
To the Editor:
I read with great interest the article
by Lawrance and colleagues,1 and I
congratulate them on this very
interesting and well-written article.
They have shown that the Cox maze
IV procedure, with its inherent
variations, can be performed bymeans2442 The Journal of Thoracic andof a less invasive right anterolateral
minithoracotomy with excellent
outcome. My personal preference is
for the classic standard ‘‘cut-and-
sew’’ Cox maze III procedure. Once
the surgeon has acquired technical
expertise, this procedure is both easy
and safe to do. What is truly important
is not the complexity of the procedure,
but rather the aortic crossclamp time.
This is the rub, and this is why
alternative energy sources for atrial
fibrillation surgery have mushroomed
in recent years. Since 2002, this
has been termed as Cox maze IV
procedure. Damiano and his working
group2 have been pioneers in this
technology. The idea proposed by
Lawrance and colleagues1 looks
promising. In addition to the mini-
mally invasive surgery, they used the
only 2 energy sources that have been
proved to be successful achieving
full transmural lesions in the atria,
bipolar radiofrequency and cryole-
sion. This great effort by Lawrance
and colleagues1 in this article high-
lights that the trend is now toward
the idea conceived by Cox3 11 years
ago. He stated that surgery for atrial
fibrillation should meet the following
conditions: (1) the procedure should
preferably be epicardial by nature;
(2) the energy source should be
capable of penetrating epicardial fat
and ablating all types of atrial fibrilla-
tion; (3) cardiopulmonary bypass
must be avoided; (4) the procedure
should be amenable to endoscopic or
minimally invasive techniques; (5) it
should be performed in less than 1
hour; and (6) hospital discharge
should be possible on the first
postoperative day. Although it is true
that not all these objectives have
been achieved, we must recognize
that we are on the right track. Novel
devices are being developed4,5; as
yet, however, transmural lesions
have not been safely produced on the
beating heart by epicardial ablation.
Unfortunately, cardiopulmonary by-
pass remains a crucial aspect to
perform this kind of procedure. TheCardiovascular Surgery c November 20most important point is that we are
going on the right direction, each
moment getting closer to the goal. I
really congratulate Lawrance and
colleagues1 for this fine and great
effort.
Ovidio A. Garcia-Villarreal, MD
Department of Cardiac Surgery
Hospital of Cardiology UMAE 34
Instituto Mexicano del Seguro Social
Monterrey, MexicoReferences
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POLYTETRAFLUOROETHY-
LENE NEOCHORDAE USED
FOR MITRALVALVE REPAIR:
DOES SIZE MATTER?
To the Editor:
In a report published in another
journal in 2007,1 we reported 2 cases
of rupture of synthetic chordae tendi-
neae (expanded polytetrafluoroethylene
[ePTFE]).Wealso analyzed thepossible
causes of what was then considered an
extremely rare finding, which had first
been reported by Buttany and14
Letters to the Editorcolleagues.2 In that report, we hypothe-
sized that, among others, inappropriate
direct manipulation of the ePTFE by
surgical instruments could be a
causative factor. Subsequently, other
groups3-6 have reported such
occurrences, which have become less
rare. This has occurred proportionally
to the worldwide expanding use of
ePTFE for mitral valve reconstruction
in the form of neochordae to replace
ruptured or elongated native chordae
or to reinforce areas of leaflet prolapse
as an alternative to resection
techniques. The isolated reports have
rendered it difficult to understand the
genesis of this event, and we are
awaiting additional analysis of the
ultrastructure of the damaged material
to shed some light on the subject.
In our initial experience, we had
used size 4-0 Gore-Tex sutures but
subsequently reverted our practice
to using 5-0 because of the
presumed greater flexibility and
smaller volume of the multiple knots
required to fix the suture to the
leaflets. Other surgeons have also
used 5-0, although some have
continued to use 4-0.
We had, until now, assumed that the
well-known strength of ePTFE was a
guaranty of integrity and have used it
liberally, for more than 20 years, in
several hundreds of cases. Recently,
however, we encountered a couple of
other cases of ruptured artificial
chordae and started to interrogate
ourselves about the correctness of
this assumption. In contrast to our first
thoughts, we have increasing concern
that the 5-0 suture might not be strong
enough to withstand the systolic
tension of the closing mitral valve
leaflets. Hence, we have chosen to
return to using the 4-0 size and wish
to draw the attention of other surgeons
to this potential problem.
Although published data have
demonstrated that even after 10 years
ePTFE chordae are still flexible and
pliable, making them indistinguishable
fromnative chordae,7 evidence has also
shown that with the progression ofThe Journaltime, artificial chordae can degenerate,
calcify, and, eventually, rupture.
Early and late rupture has now been
reported with both sizes of ePTFE
suture; hence, other factors could
be involved; however, a little more
strength certainly will do no harm.
Manuel J. Antunes, PhD
Gonc¸alo F. Coutinho, MD
Centre of Cardiothoracic Surgery
University Hospital and Medical
School
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SYMPATHECTOMYAND
INCIDENCE OR SEVERITY OF
COMPENSATORY
HYPERHIDROSIS
To the Editor:
We read with keen interest the
article by Gunn and colleagues1
regarding their opinion on extension
of sympathectomy for the treatment
of primary hyperhidrosis and occur-
rence of compensatory hyperhidrosisof Thoracic and Cardiovascular Surger(CH). Their retrospective review of
an unrandomized series of patients
suggested that severe CH was rare
and occurred irrespective of the level
or extension of sympathectomy.
From a methodologic point of view,
retrospective studies are, undoubtedly,
inferior to prospective assessments,
and randomized prospective trials are
significantly superior to the former.
There have been prospective and
randomized studies relating greater
frequency and discomfort of CH
after more proximal and extended
sympathectomy.2-4 In these studies,
different patients were randomly
assigned to undergo bilateral
symmetric sympathectomies (eg, a
patient was randomly assigned to
undergo bilateral T4 sympathectomy,
and another patient was randomly
assigned to undergo bilateral
T3-T4 sympathectomy). For palmar
and axillary hyperhidrosis, CH was
reported with lower frequency in
less extensive and less proximal
sympathectomies.
A study by Katara and coworkers5
had a different design, in which all
patients underwent operation on one
side with an extensive sympathectomy
(T2-T3) and on the other with a more
limited sympathectomy (T2). The side
of extensive sympathectomy was
randomly determined (left vs right),
but all patients had an extensive
sympathectomy on one side and a
limited sympathectomy on the other.
Their results showed, at best, that after
an extensive sympathectomy on one
side, most patients would have CH
bilaterally despite a less extensive
(T2 only) sympathectomy on the other
side.
We believe that extreme caution
must be taken if one considers, from
a single institutional and retrospective
review, that extended sympathectomy
does not influence the outcome of CH,
when prospective and randomized
studies have suggested otherwise.
CH, when present, may become a
difficult situation to deal with, and
extreme caution must be taken toy c Volume 148, Number 5 2443
